MARINOL Capsules are indicated for nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments.
Treatment of Chemotherapy-Induced Emesis:1
Combination antiemetic therapy with MARINOL Capsules and a phenothiazine (prochlorperazine) may result in synergistic or additive antiemetic effects and attenuate the toxicities associated with each of the agents.
The pharmacologic effects of MARINOL Capsules are dose-related and subject to considerable interpatient variability. Therefore, dosage individualization is critical in achieving the maximum benefit of MARINOL Capsules treatment.
*MOPP refers to a chemotherapy combination comprised of Mustargen®, Oncovin®, procarbazine, and prednisone.2
MARINOL Capsules Dose: Response Frequency and Adverse Experiences† (N=50 treatment courses)
|MARINOL Capsules Dose||Response Frequency (%)||Adverse Events Frequency (%)|
†Nondysphoric events consisted of drowsiness, tachycardia, etc.